AB0430 Subjective assessments of patients with rheumatoid arthritisreported that bio-holiday therapy brought them financial and psychological improvements
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.4411
Abstract: Background At EULAR 2016 and 2017 we reported that it is possible to maintain disease activity, radiographic progression, physical function, and bone metabolism status in rheumatoid arthritis (RA) patients with clinical disease activity index (CDAI)… read more here.
Keywords: bio holiday; holiday therapy; remission; cdai remission ... See more keywords
AB0233 ATTAINING CDAI REMISSION IS THE FIRST GATEWAY TO ATTAIN BOOLEAN REMISSION
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.1550
Abstract: Background: Boolean remission is most stringent but most comparable remission status for the patient with rheumatoid arthritis (RA). Clinical remission evaluated with clinical disease activity index (CDAI) is also one of the most popular index… read more here.
Keywords: boolean remission; score; cdai; cdai remission ... See more keywords
Tight control in patients with rheumatoid arthritis treated with targeted therapies across the COVID-19 pandemic era
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Telemedicine and Telecare"
DOI: 10.1177/1357633x221150724
Abstract: Objectives To analyze the impact of different patterns of healthcare delivery on remission of rheumatoid arthritis (RA) patients treated with targeted therapies during the first wave (2020) and second/third waves (2021) of the pandemic compared… read more here.
Keywords: targeted therapies; three periods; rheumatoid arthritis; treated targeted ... See more keywords